Veradigm | MDRX - Debt


Veradigm reported $200.33M in Debt for its fiscal quarter ending in September of 2022.





Debt Change Date
Alcidion AUD 1.37M 329K Dec/2024
Ambu A/S DKK 557M 23M Dec/2025
Amplifon EUR 1.83B 324.15M Jun/2025
Cardinal Health USD 9.03B 505M Sep/2025
Centene USD 17.58B 6M Sep/2025
Charles River Laboratories USD 2.63B 157.4M Sep/2025
Cigna USD 34.04B 3.27B Sep/2025
Coloplast 18.67B 35M Sep/2023
Computer Programs Systems USD 141.89M 2.67M Sep/2023
Convatec Group USD 1.2B 210.3M Dec/2024
CVS Health USD 64.57B 1.27B Dec/2025
Diasorin EUR 769.18M 97.18M Jun/2025
Elevance Health USD 32.05B 56M Dec/2025
General Electric Aerospace USD 20.49B 344M Dec/2025
Gulf Medical Proj AED 7.67M 1.75M Mar/2025
Humana USD 12.37B 238M Dec/2025
IQVIA Holdings USD 15.72B 767M Dec/2025
Laboratory Of America USD 6.53B 16.1M Sep/2025
Maximus USD 1.44B 336.35M Sep/2025
McKesson USD 9.79B 141M Sep/2025
Med Life RON 1.94B 52.08M Sep/2025
Molina Healthcare USD 3.85B 289M Sep/2025
Omnicell USD 206.78M 177.63M Sep/2025
Oriola-kd EUR 76.1M 13M Dec/2024
Owens Minor USD 1.95B 91.18M Mar/2025
Quest Diagnostics USD 6.38B 2M Sep/2025
Rede D'or Sao Luiz BRL 49.96B 8.38B Dec/2025
Siemens Healthineers EUR 756M 21M Sep/2025
Sonova Holding CHF 1.91B 130.9M Jun/2023
Supermax Corporation Bhd MYR 164.16M 15.6M Sep/2025
UnitedHealth USD 78.39B 1.75B Dec/2025
Veeva Systems USD 89.8M 4.35M Sep/2025
Veradigm USD 200.33M 431K Sep/2022
Xerox USD 3.3B 101M Mar/2025